Errors in health care management: What do they cost?

Quality in Health Care

Volumn 9, Issue 4, 2000, Pages 216-221

  Rigby, K D ^a   Litt, J C B ^b  

^a Australian Patient Safety Foundation Inc   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Costs; Iatrogenic injuries

Indexed keywords

ARTICLE; AUSTRALIA; DISABILITY; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HOSPITAL COST; IATROGENIC DISEASE; INCIDENCE; MEDICAL AUDIT; UNITED STATES;

AUSTRALIA; COST ALLOCATION; DATA COLLECTION; HOSPITAL COSTS; HUMANS; IATROGENIC DISEASE; INCIDENCE; MEDICAL ERRORS; NATIONAL HEALTH PROGRAMS; QUALITY ASSURANCE, HEALTH CARE; RANDOM ALLOCATION; RETROSPECTIVE STUDIES; SAMPLING STUDIES;

EID: 0034534965     PISSN: 09638172     EISSN: None     Source Type: Journal    
DOI: 10.1136/qhc.9.4.216     Document Type: Article

References (25)

1. The quality in Australian Health Care Study
2. The nature of adverse events in hospitalised patients: Results of the Harvard Medical Practice Study 11
3. Incidence of adverse events and negligence in hospitalised patients
4. An analysis of the causes of adverse events from the 'quality in health care study
5. Iatrogenic diseases as a reason for admission to the intensive care unit
6. The health care cost of drug-related morbidity and mortality in nursing facilities
7. The high cost of low-frequency events: The anatomy and economics of surgical mishaps
8. The economic consequences of medical injuries. Implication for a no-fault insurance plan
9. Preventing medical injury
10. Estimating the cost of hospital treatment for injuries using linked morbidity data
11. Cost-of-illness studies
12. Cost of illness studies: An aid to decision-making?
13. Promoting health care quality: What role performance indicators?
14. The costs of adverse events in hospitalised patients
15. The cost infection in surgical patients: A case-control study
16. Prophylaxis for venous thromboembolism in hip fracture surgery: Total costs and cost effectiveness in The Netherlands
17. Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation
18. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation
19. Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective